Home / News / TissueGen partnerships & expansions fuel strong 2013

TissueGen partnerships & expansions fuel strong 2013

05 Feb '14
3 min read

TissueGenInc., developer of a groundbreaking biodegradable fiber format for drug delivery, had a significant year in 2013 marked by strengthened relationships with key players in drug delivery and medical device industries. 
 
The company rolled out its first commercially available product in Q2 and ended the year by moving to a state-of-the-art facility that will enable manufacturing of high quality products consistently meeting exact medical standards.
 
In its new location, TissueGen will benefit from an on-site certified clean room and extrusion room facilities. These enhanced capabilities will be essential as the company continues to focus on commercialization of its proven technology for advanced drug delivery and sustained therapeutic release.  Additionally, TissueGen will apply for ISO 13485 certification this year to further enhance the value delivered to its material provider customers.
 
Earlier in 2013, TissueGen announced its first commercially available product, ELUTE biodegradable drug-loaded fiber, including pharmaceutical loaded fibers and growth factor loaded fibers.
 
The company’s patented core technology includes fiber extrusion at room temperature, thereby preserving the biological activity of incorporated drugs and therapeutic agents—expanding the selection of drugs that may be directly incorporated into implantable medical devices.
 
“2013 was a major year for TissueGen as we moved from R&D to full commercialization of our core technology,” said Christopher Knowles, President and CEO of TissueGen. “We are focused on building strong relationships with industry partners and medical device customers who value TissueGen as a material provider for the implantable medical device market. 
 
We now offer a streamlined manufacturing process to deliver our novel biodegradable drug-loaded fiber materials to the medical device industry. Having an industrially clean lab environment with an ISO 7 certified cleanroom will enable our engineers to perform advanced nanoparticle development and to deliver high quality fiber products.”

Leave your Comments

Secant Medical launches website for advanced biomaterials
Secant Medical launches website for advanced biomaterials
Suominen Corp convertible hybrid bond oversubscribed
Suominen Corp convertible hybrid bond oversubscribed

Follow us